Intuitive Surgical stock support test: Key levels to watch

Traders Union
All News
Stocks
Intuitive Surgical drops 5.01% today

Highlights

Intuitive Surgical reported Q2 2026 revenue of $2.89 billion, up 19% year over year, with adjusted EPS of $2.80, exceeding consensus by $0.30.
Recurring sources accounted for 85% of total revenue, but market share concerns and continued conservative guidance limited gains.
Shares of Intuitive Surgical fell 5.01% and remain under sustained seller control, with a projected trading range of $367.87 to $384.55 and a 76% probability of further downside.

Earnings beat drives revenue optimism as guidance and competition weigh

Intuitive Surgical reported fiscal Q2 2026 results with revenue rising 19% to $2.89 billion and adjusted EPS of $2.80, exceeding consensus estimates by $0.30, according to Finance Yahoo. This earnings outperformance highlights strong operational execution and growth in the installed base, with approximately 85% of total revenue coming from recurring sources noted by Finance Yahoo. However, gains were tempered by increased market share concerns following regulatory clearances obtained by competitors and the company’s continuation of conservative full-year guidance, factors that weighed on sentiment after the report.

Overhead resistance caps upside amid persistent momentum weakness

ISRG is encountering overhead resistance with the Ichimoku Kijun set at $397.17. On the hourly chart, price trades below both the MA-20 and MA-50, while remaining well under the MA-200 on the daily timeframe. Momentum signals support the current weakness: RSI and CCI both indicate a Sell, with Stoch RSI deep in the Oversold zone and Bull/Bear Power pointing to clear seller dominance. The MACD remains neutral, while ADX signals a Sell and the Awesome Oscillator aligns with the ongoing downward momentum. Today’s session has seen high volatility, price slumping toward session lows with pronounced intraday selling pressure.

Downside risk prevails as range-bound trade and volatility persist

In the short term, ISRG is expected to remain range-bound between support at $367.87 and resistance at $384.55. The probability of a downside move is estimated at 76%, while an upward move has a 24% likelihood. The baseline scenario calls for continued consolidation within this volatility band. A break below $367.87 may accelerate further declines, while recovery attempts would need to overcome resistance at $397.17 to trigger a bullish reversal.

Viktoras Karapetjanc, Traders Union expert, highlights that Intuitive Surgical’s robust Q2 2026 results reinforce the company’s fundamental strength and recurring revenue profile. He sees the recent launch of the Malaysia facility and updates to the da Vinci 5 platform as positive drivers for long-term growth. However, Karapetjanc notes that near-term sentiment was dampened by market share concerns and ongoing conservative guidance, justifying the current short-term weakness. "Despite recent volatility, strong fundamentals and recurring revenues position ISRG well for recovery once resistance at $384.55 is cleared."

Earlier, analysts noted that Intuitive Surgical's strong operational and financial performance had supported expectations for continued upside. Current trading weakness and heightened competitive pressures now introduce meaningful downside risk, making support at $367.87 a critical level to watch for potential further declines.

Source of Data: ISRG Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.